Stroke Trial, Recruiting NCT07247838 Sponsor: Affiliated Hospital of Nantong University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07247838
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are having their first-ever acute ischemic stroke (a stroke caused by a blocked blood vessel) and who have had their first samples collected within 48 hours of symptoms starting and being admitted to hospital
  • People who are 18 years of age or older (any gender is eligible)
  • People whose stroke has been rated at a severity score of 4 or higher on a standard medical stroke scale called the NIHSS
  • People who fully understand what the study involves and have agreed to take part by signing a consent form

Who may not be able to join:

  • People who have taken antibiotics or probiotics in the month before being admitted to hospital, or during the follow-up period
  • People who have an active infection such as pneumonia or a urinary tract infection
  • People from whom stool (bowel) samples cannot be collected within three days of being admitted to hospital, or during the three-month follow-up period
  • People with serious problems affecting major organs such as the heart, lungs, liver, or kidneys
  • People who have not given, or are not able to give, their consent to take part in the study
  • People who have a history of significant digestive or bowel conditions
  • People who have another serious condition affecting the brain or nervous system
  • People who the trial investigators consider unsuitable for the study for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiao MB Director of scientific research Department, Doctor, Affiliated Hospital of Nantong University

Phone: 13962988003

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Affiliated Hospital of Nantong University
Registry
ClinicalTrials.gov
Start date
19 November 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Gut microbiota composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov